A phase III, double-blind, comparative study of NE-58095 (once-monthly formulation)

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2010
INTERVENTION: Intervention name : NE‐58095 Dosage And administration of the intervention : Oral Control intervention name : NE‐58095 Dosage And administration of the control intervention : Oral CONDITION: Involutional osteoporosis PRIMARY OUTCOME: Mean lumbar spine bone mineral density (BMD) INCLUSION CRITERIA: [Main inclusion criteria] ‐Aged 50 years or older at the time of obtaining consent ‐Female subjects must be at least 2 years postmenopausal (i.e., at least 2 years since last menstrual period)
Epistemonikos ID: 9ddf1bc1acf9799d4872294e4927fc34e2d46a95
First added on: Aug 22, 2024